Canada · Health Canada Drug Product Database

MATERNA - TAB

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
34565
DIN
02170043
Form
Tablet
Company as listed by source
WYETH-AYERST CANADA INC.
Source status
Cancelled Post Market (2001-08-03)
Source last updated
2025-03-22

Source-listed ingredients

  • DL-ALPHA TOCOPHERYL ACETATE — 30 UNIT
  • ASCORBIC ACID — 100 MG
  • FOLIC ACID — 1 MG
  • THIAMINE MONONITRATE — 3 MG
  • VITAMIN B2 — 3.4 MG
  • NICOTINAMIDE — 20 MG
  • PYRIDOXINE HYDROCHLORIDE — 10 MG
  • VITAMIN B12 — 12 MCG
  • VITAMIN D3 — 250 UNIT
  • BIOTIN — 30 MCG
  • D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) — 10 MG
  • CALCIUM (CALCIUM CARBONATE) — 250 MG
  • MAGNESIUM (MAGNESIUM OXIDE) — 50 MG
  • IODINE (POTASSIUM IODIDE) — .15 MG
  • IRON (FERROUS FUMARATE) — 60 MG
  • COPPER (CUPRIC OXIDE) — 2 MG
  • ZINC (ZINC OXIDE) — 25 MG
  • CHROMIUM (CHROMIC CHLORIDE) — 25 MCG
  • MANGANESE (MANGANESE SULFATE) — 5 MG
  • MOLYBDENUM (SODIUM MOLYBDATE) — 25 MCG
  • BETA-CAROTENE — 1500 UNIT
  • VITAMIN A ACETATE — 1500 UNIT

These values do not establish equivalence or a dose recommendation.

Packages

  • 4/100

Source and coverage

Open Health Canada Drug Product Database →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →